Update on Acquisition

RNS Number : 5474H
Path Investments plc
07 April 2022
 

7 April 2022

 

Path Investments plc
("Path" or the "Company")

Update on Acquisition

 

Path Investments plc (TIDM: PATH), is pleased to confirm that, following the passing of all resolutions at its General Meeting ("GM") held on 1 April 2022, that all other conditions precedent in respect of the acquisition of DG Innovate Limited (the "Acquisition") have been satisfied or waived, apart from the admission to the Standard Listing segment of the Official List and trading on the Main Market of the London Stock Exchange ("Admission"). Admission is expected to occur at 8am on 8 April 2022 at which time the Acquisition will complete.

 

The Company has made an application for the Admission of , in aggregate, 6,813,251,305 New Ordinary Shares being 5,397,451,305 Initial Consideration Shares, 830,800,000 Warrant Shares, 510,000,000 Subscription Shares and 75,000,000 Fee Shares and for the readmission of the Company's Existing Ordinary Shares.

 

Total Voting Rights

 

The total number of Ordinary Shares on Admission will be 8,842,715,107 and the total number of voting rights in the Company will be 8,842,715,107 which is the number that may be used by the shareholders as the denominator for calculations by which they will determine if they are required to notify their interest in, or a change to their interests in, the Company under the FCA's Disclosure and Transparency Rules.

 

Capitalised terms not otherwise defined in this announcement have the same meaning as ascribed to them in the Prospectus dated 14 March 2022.

For further information please contact:

Path Investments plc

C/O IFC

Jack Allardyce




IFC Advisory (Financial PR & IR)

020 3934 6630

Zach Cohen




Grant Thornton UK LLP (Financial Adviser)

Daphne Zhang

Ciara Donnelly

020 7383 5100

 



ETX Capital (Broker)

020 7392 1400


 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDUNABRUAUSRAR

Companies

DG Innovate (DGI)
UK 100

Latest directors dealings